In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ArQule completes $70.87mm follow-on offering

Executive Summary

Small-molecule synthesis and optimization company ArQule sold 3.36mm common shares at $22.50 apiece in a follow-on public offering (including the 438k-share overallotment), netting about $70.87mm. The company increased the number of shares from its original October filing of 2.5mm shares.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies